GLUD1 and hepatocellular carcinoma: Altogether, our findings contribute to a better understanding of the role of GLUD1 and its regulatory mechanisms in HCC and highlight the clinical and biological basis for developing GLUD1 as a novel diagnostic and therapeutic marker for tumors, especially HBV-related HCC.